Outcomes and costs within a disease management program for advanced congestive heart failure

American Heart Journal

Volumn 135, Issue 6 II SUPPL., 1998, Pages

  Schulman, K A ^a   Mark, D B ^a   Califf, R M ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIGOXIN; ENALAPRIL; FUROSEMIDE; PROSTACYCLIN;

CLINICAL TRIAL; CONGESTIVE HEART FAILURE; COST BENEFIT ANALYSIS; COST OF ILLNESS; DRUG COST; HEALTH STATUS; HUMAN; MORBIDITY; MORTALITY; PATIENT SATISFACTION; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; TREATMENT OUTCOME; TREATMENT PLANNING;

EID: 0031857019     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0002-8703(98)70256-x     Document Type: Review

References (24)

1. RF. Gillum Epidemiology of health failure in the United States Am Heart J 126 1993 1042 1047
2. S Yusuf T Thom RD. Abbott Changes in hypertension treatment and in congestive heart failure in the United States Hypertension 13 suppl 5 1989 I-74 I-79
3. JK Ghali R Cooper E. Ford Trends in hospitalization rates for heart failure in the United States, 1973-1986: evidence for increased population prevalence Arch Intern Med 150 1990 769 773
4. J Daley S Jencks D Draper G Lenhart N Thomas J. Walker Predicting hospital-associated mortality for Medicare patients JAMA 260 1988 3617 3628
5. JB O'Connell MR Bristow Economic impact of heart failure in the United States: time for a different approach J Heart Lung Transplant 13 1993 S107 S112
6. Cardiovascular Health Studies Branch Centers for Disease Control Mortality from congestive heart failure United States, 1980-1990 MMWR 43 1994 77 81
7. MA Konstam K Dracup DW Baker M Bottorff NH Brooks RA Dacey Heart failure: evaluation and care of patients with left-ventricular systolic dysfunction Publication No. 94-0612 June 1994 US Department of Health and Human Services, US Public Health Service, Agency for Health Care Policy and Research, Rockville (MD)
8. H Glick J Cook B Kinosian B Pitt M Bourassa H Pouleur Costs and effects of enalapril therapy in patients with symptomatic heart failure: an economic analysis of the Studies of Left Ventricular Dysfunction (SOLVD) treatment trial J Cardiac Failure 1 1995 371 380
9. KA Schulman M Buxton H Glick M Sculpher G Guzman J Kong for the First Investigators Results of the economic evaluation of the FIRST study: a multinational prospective economic evaluation IJTAHC 12 4 1996 698 713
10. MW Rich V Beckham C Wittenburg CL Leven KE Freedland RM. Carney A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure N Engl J Med 333 1995 1190 1195
11. S Greenfield W Rogers M Mangotich MF Carney AR. Tarlov Outcomes of patients with hypertension and non-insulin dependent diabetes mellitus treated by different systems and specialities: results from the medical outcomes study JAMA 274 1995 1436 1444
12. JG Jollis ER DeLong ED Peterson LH Muhlbaier DF Fortin RM Califf Outcome of acute myocardial infarction according to the specialty of the admitting physician N Engl J Med 335 1996 1880 1887
13. Institute of Medicine Clinical Practice Guidelines: Directions for a New Program 1990 National Academy Press Washington, DC
14. SD Person D Goulart-Fisher TM. Lee Critical pathways as a strategy for improving care: problems and potential Ann Intern Med 1123 1995 941 948
15. M Weinberger EZ Oddone WG. Henderson Does increased access to primary care reduce hospital readmissions? N Engl J Med 334 1996 1441 1447
16. D Blumenthal AM. Epstein Part 6: The role of physicians in the future of quality management N Engl J Med 335 1996 1328 1331
17. MR. Chassin Improving the quality-of-care debate N Engl J Med 335 1996 1060 1063
18. DM Berwick AB Godfrey J. Roessner Curing health care: new strategies for quality improvement 1990 Jossey-Bass San Francisco
19. The International Classification of Diseases. 9th revision. Clinical modification 1986 Commission on Professional and Hospital Activities Ann Arbor
20. American Medical Association Physicians' Current Procedural Terminology, CPT'94 1993 American Medical Association Chicago
21. DB Mark MA Hlatky RM Califf CD Naylor KL Lee PW Armstrong Cost effectiveness of thrombolytic therapy with tissue plasminogen activator as compared with stretokinase for acute myocardial infarction N Engl J Med 332 1995 1418 1424
22. MA Hlatky WJ Rogers I Johnstone D Boothroyd NM Brooks B Pitt Medical care costs and quality of life after randomization to coronary angioplasty or coronary bypass surgery N Engl J Med 336 1997 92 99
23. Procedures manual: Flolan study 48. A survival trial in severe congestive heart failure 1991 Burroughs Wellcome Co
24. Luft H. Health maintenance organizations: dimensions of performance. New Brunswick (CT): Transition Books.